Results 171 to 180 of about 57,330 (350)

Fixed Drug Eruption to Levocetirizine: A Case Report

, 2023
Dennis Henry, Vishal Methre, Yumjom Padu
openalex   +1 more source

Efficacy and safety of brodalumab in palmoplantar pustulosis: A 68‐week randomized Phase 3 trial

Journal of the European Academy of Dermatology and Venereology, EarlyView.
This open‐label study is a continuation of the 16‐week double‐blind, Phase 3 trial assessing the efficacy and safety of brodalumab 210 mg subcutaneously, till a 68‐week extension period. Continued improvement was seen in the PPPASI 50/75/90 responses, PPPSI scores, PGA 0/1 responses and DLQI. Abstract Background The efficacy and safety of brodalumab in
Masamoto Murakami, Yukari Okubo, Satomi Kobayashi, Natsuko Kikuta, Yoshiumi Ouchi, Kenta Shishido, Tadashi Terui   +6 more
wiley   +1 more source

Drug points: Psoriasiform eruptions associated with penicillamine [PDF]

, 1987
Jennifer Forgie, A. S Highet
openalex   +1 more source

Bullous fixed drug eruption associated with ibuprofen. [PDF]

CMAJ
Wen HY, Gao XH.
europepmc   +1 more source

Dermatology 2.0: Precision medicine for inflammatory skin diseases

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Digital immune mapping of transcriptomics profiles from inflammatory skin disease biopsies enables precise molecular diagnosis, quantification of immune modules and personalized therapy selection by matching dominant immune signatures to targeted treatments.
Jeremy Di Domizio, Antoine Girardin, Curdin Conrad, Teofila Seremet, Michel Gilliet   +4 more
wiley   +1 more source

Generalized Bullous Fixed Drug Eruption Secondary to Levocetirizine: A Lesson Learned! [PDF]

Clin Case Rep
Mathur M, Paudel S, Bhattarai N, Karki S, Regmi S.   +4 more
europepmc   +1 more source

Fixed drug eruption and generalized bullous fixed drug eruption: Insights from an analysis of the FDA Adverse Event Reporting System [PDF]

Pragya Shrestha, C. Addison Stone, Elizabeth J. P. Phillips   +2 more
openalex   +1 more source

Pityriasis rosea-like drug eruption due to bupropion [PDF]

, 2014
Mualla Polat, Özge Uzun, İsmail Örs, Çetin Boran   +3 more
openalex   +1 more source

Cell Therapy for Periodontal, Soft‐Tissue, and Craniofacial Regeneration

Journal of Periodontal Research, EarlyView.
The clinical translation of mesenchymal stem/stromal cells (MSCs) represents a major advancement in dentistry, especially for periodontal, soft‐tissue, and craniofacial regeneration. However, several challenges remain to be addressed, including the absence of standardised protocols, limited scalability, regulatory hurdles, a lack of well‐controlled ...
Kamal Mustafa, Shuntaro Yamada, Nerea Sanchez, Magdalena Mayol, Cecilie Gjerde, Mariano Sanz   +5 more
wiley   +1 more source

Clinicopathological Characteristics of Lichenoid Drug Eruption: A 17-Year Retrospective Study. [PDF]

Clin Cosmet Investig Dermatol
Promsena P, Iamsumang W, Rutnin S.
europepmc   +1 more source